GGrantIndex
Sort

78,016 grants matching breast cancer

Diagnosis and Treatment of APOBEC Mutagenesis in Metastatic Breast Cancer

$445,626
Sarat Chandarlapaty · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA

An Integrated Systems Approach for Incompletely Penetrant Onco-phenotypes.

$445,618
Kevin A Janes · University Of Virginia · U01 · FY2018 · CA

Monitoring neoadjuvant chemotherapy of breast cancer using 3D subharmonic aided pressure estimation

$445,562
Kibo Nam · Thomas Jefferson University · R37 · FY2023 · CA

Targeting macrophages in metastatic cancer

$445,546
Anthony Rongvaux · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA

TRASTUZMAB OR A TKI ACTIVATES NOTCH 1 IN BREAST CANCER: NOVEL THERAPEUTIC OPPORTUNITIES USING NOTCH INHIBITORS

$445,501
Loyola University Of Chicago · · FY2008 · Department of the Army

Genetics of Breast Cancer Risk at Windows of Exposure

$445,500
Michael N Gould · University Of Wisconsin-Madison · U01 · FY2010 · ES

METABOLIC REORGANIZATION IN BREAST CANCER EPITHELIAL CELLS: ROLE OF THE PENTOSE PHOSPHATE SHUNT

$445,500
University Of Florida · · FY2008 · Department of the Army

Role of Th2 cytokines in progenitor-mediated formation of tumor lymphatics

$445,500
Sophia Ran · Southern Illinois University Sch Of Med · R15 · FY2024 · CA

DEVELOPMENT OF BIODEGRADABLE ZINC OXIDE NANOWIRES TARGETING BREAST CANCER METASTASIS

$445,454
University Of Wisconsin System · · FY2011 · Department of Defense

Multi-cancer Early Detection

$445,446
John Kisiel · Mayo Clinic Rochester · R01 · FY2025 · CA

Genetic Modifiers of Cancer Risk

$445,441
Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA

PROGRAM LEADERS

$445,434
Eric R. Fearon · University Of Michigan At Ann Arbor · P30 · FY2009 · CA

Role of CD36 and diet-derived fatty acids in breast cancer

$445,431
Manabu Kurokawa · Kent State University · R15 · FY2021 · CA

Activation of the beta-3 integrins: Role of the kindlins

$445,407
Edward Franklin Plow · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · HL

KanSurvive: Testing a model for improving cancer survivorship care in rural practice

$445,360
Jennifer Rose Klemp · University Of Kansas Medical Center · R01 · FY2020 · CA

Developmental Funds

$445,321
Suresh S Ramalingam · Emory University · P30 · FY2023 · CA

Training Program in Cancer Biology

$445,315
Massachusetts General Hospital · T32 · FY2005 · CA

Single-Cell & Computational Biology Core

$445,278
Kivanc Birsoy · Rockefeller University · U54 · FY2025 · CA

SUMO Modification and Cancer Therapy

$445,267
Yuan Chen · Beckman Research Institute/City Of Hope · R01 · FY2017 · GM

Cell and Chemical Biology of Microtubules

$445,267
Timothy J Mitchison · Harvard Medical School · R35 · FY2019 · GM

PRO-APOPTOTIC BREAST CANCER NANOTHERAPEUTICS

$445,263
Northwestern University · · FY2010 · Department of Defense

Three-dimensional organoid models to study breast cancer progression

$445,227
Shilpa Sant · University Of Pittsburgh At Pittsburgh · R37 · FY2018 · CA

Microchannel cell-based assays to enable cancer research

$445,216
David J Beebe · University Of Wisconsin-Madison · R33 · FY2009 · CA

NIMHD Adjunct Investigator Program

$445,212
Anna Maria Napoles · National Institute On Minority Health And Health Disparities · ZIJ · FY2022 · MD

FY14 BREAST CANCER RESEARCH PROGRAM - BREAKTHROUGH AWARD FUNDING LEVEL 1-PARTNERING PI OPTION

$445,206
The Leland Stanford Junior University · · FY2015 · Department of Defense